213476-12-1 (右旋兰索拉唑杂质A,Lansoprazole N-Oxide)

右旋兰索拉唑杂质A;兰索拉唑杂质I;2-(((3-甲基-1-氧代-4-(2,2,2-三氟乙氧基)-2-吡啶基)甲基)亚磺酰基)-1H-苯并咪唑;2-[[[3-甲基-1-氧代-4-(2,2,2-三氟乙氧基)-2-吡啶]甲基]亚硫酰基]苯并咪唑;兰索拉唑;兰索拉唑EP杂质A;兰索拉唑N-氧化物;兰索拉唑杂质A(EP) 标准品;2-[[[3-甲基-1-氧代-4-(2,2,2-三氟乙氧基)-2-吡啶基]甲基]亚磺酰基]-1H-苯并咪唑;兰索拉唑杂质A (氮氧化物);

Lansoprazole N-Oxide;1H-Benzimidazole, 2-[[[3-methyl-1-oxido-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-;2-[[3-methyl-1-oxido-4-(2,2,2-trifluoroethoxy)pyridin-1-ium-2-yl]methylsulfinyl]-1H-benzimidazole;LANSOPRAZOLE EP IMPURITY A (""N-OXIDE"");UNII-51C3Z1Q9J3;2-(((1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine 1-oxide;Lansoprazole Imp. A;SCHEMBL13841008;2-[(RS)-[[3-Methyl-1-oxido-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulphinyl]-1H-benzimidazole (Lansoprazole N-Oxide);213476-12-1;1346604-20-3;Lansoprazole EP Impurity A;LANSOPRAZOLE IMPURITY A [EP IMPURITY];AS-82621;1H-BENZIMIDAZOLE, 2-(((3-METHYL-1-OXIDO-4-(2,2,2-TRIFLUOROETHOXY)-2-PYRIDINYL)METHYL)SULFINYL)-;LansoprazoleN-oxide;2-[(RS)-[[3-Methyl-1-oxido-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulphinyl]-1H-benzimidazole; Lansoprazole Imp. A (EP); Lansoprazole N-Oxide; Lansoprazole Impurity A;LANSOPRAZOLE IMPURITY, LANSOPRAZOLE N-OXIDE- [USP IMPURITY];2-((RS)-((3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)PYRIDIN-2-YL)METHYL)SULFINYL)-1H-BENZIMIDAZOLE;Lansoprazole-d4N-Oxide;BCP17470;F19338;OBGHBYDDJGHGNS-UHFFFAOYSA-N;EN300-20041979;A1-03883;2-[(1H-1,3-BENZODIAZOLE-2-SULFINYL)METHYL]-3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)PYRIDIN-1-IUM-1-OLATE;Q27260891;51C3Z1Q9J3;

MFCD22380629

OBGHBYDDJGHGNS-UHFFFAOYSA-N

1S/C16H14F3N3O3S/c1-10-13(22(23)7-6-14(10)25-9-16(17,18)19)8-26(24)15-20-11-4-2-3-5-12(11)21-15/h2-7H,8-9H2,1H3,(H,20,21)

S(C1=NC2C=CC=CC=2N1)(CC1C(C)=C(C=C[N+]=1[O-])OCC(F)(F)F)=O

29309090